Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia

Clinical trial NCT01423149 · COMPLETED

Trial details

NCT number: NCT01423149
Sponsor: Mateon Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Choroidal Neovascularization Myopia, Degenerative

Start date: 2005-03-01
Primary completion: 2007-01-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.